Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study

PloS One
Ruth OwusuSeth Owusu-Agyei

Abstract

Sulphadoxine-Pyrimethamine (SP) is still the only recommended antimalarial for use in intermittent preventive treatment of malaria during pregnancy (IPTp) in some malaria endemic countries including Ghana. SP has the potential to cause acute haemolysis in G6PD deficient people resulting in significant haemoglobin (Hb) drop but there is limited data on post SP-IPTp Hb drop. This study determined the difference, if any in proportions of women with significant acute haemoglobin drop between G6PD normal, partial deficient and full deficient women after SP-IPTp. Prospectively, 1518 pregnant women who received SP for IPTp as part of their normal antenatal care were enrolled. Their G6PD status were determined at enrollment followed by assessments on days 3, 7,14 and 28 to document any adverse effects and changes in post-IPTp haemoglobin (Hb) levels. The three groups were comparable at baseline except for their mean Hb (10.3 g/dL for G6PD normal, 10.8 g/dL for G6PD partial deficient and 10.8 g/dL for G6PD full defect women).The prevalence of G6PD full defect was 2.3% and 17.0% for G6PD partial defect. There was no difference in the proportions with fractional Hb drop ≥ 20% as compared to their baseline value post SP-IPTp among the 3 gr...Continue Reading

References

Nov 20, 1976·British Medical Journal·T K ChanS C Tso
Apr 4, 2000·Tropical Medicine & International Health : TM & IH·J MayU Bienzle
Jan 2, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·F P MockenhauptU Bienzle
Feb 13, 2003·Tropical Medicine & International Health : TM & IH·Frank P MockenhauptUlrich Bienzle
Mar 26, 2004·Tropical Medicine & International Health : TM & IH·H L GuyattR W Snow
Jan 8, 2008·Lancet·M D Cappellini, G Fiorelli
Mar 3, 2010·PloS One·Clara MenéndezPedro L Alonso
Aug 13, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ilan YoungsterMatitiahu Berkovitch
Jul 8, 2011·The American Journal of Tropical Medicine and Hygiene·Nana O WilsonJonathan K Stiles
Jan 1, 2014·British Journal of Haematology·Lucio Luzzatto, Elisa Seneca

❮ Previous
Next ❯

Software Mentioned

Access
Stata

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.